Press Releases

YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

Sep 30, 2025 05:25 PM

TAIWAN, Sept. 30, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio Ltd” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and...
YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

Aug 28, 2025 02:33 PM

Strategic Move Positions YD Bio Limited for Accelerated Innovation and Market ExpansionTrading of common stock and warrants of the new public company, YD Bio Limited, is expected to commence on the...
Breeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited

Sep 25, 2024 07:30 AM

YD Biopharma is a Clinical-Stage Biopharmaceutical Company Focusing on Cancer Prevention Diagnostics and Seeking to Transform the Treatment of a Wide Spectrum of Diseases Pro Forma for the...